A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
OSE2101 Versus Chemotherapy in HLA-A2 Positive Patients With Advanced NSCLC After Immune Checkpoint Inhibitor Failure
- Status
- TERMINATED
- Phase
- PHASE3
Docetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel and Cyclophosphamide (ADVANCE)
- Status
- COMPLETED
- Phase
- PHASE3
Nedaplatin/Docetaxel Versus Cisplatin/Docetaxel in Treatment of Advanced/Relapsed Squamous Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Trametinib and Docetaxel in Treating Patients With Recurrent or Stage IV KRAS Mutation Positive Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
TA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA Signature
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
Neoadjuvant Chemotherapy With or Without Huaier Granule in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery
- Status
- RECRUITING
- Phase
- PHASE4
Comparison Between XELOX and S1, Oxaliplatin and Docetaxel as Neoadjuvant Chemotherapy for Gastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Effect of Triple Combination of Induction, Concurrent and Adjuvant Chemotherapy in High Risk Nasopharyngeal Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
Efficacy Study of Nivolumab Compared to Docetaxel in Subjects Previously Treated With Advanced or Metastatic Non Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Comparative Analysis of the Efficacies in Neoadjuvant Chemotherapy of Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Study of Pembrolizumab (MK-3475) in Platinum Pre-treated Recurrent/Metastatic Nasopharyngeal Cancer (MK-3475-122/KEYNOTE-122)
- Status
- COMPLETED
- Phase
- PHASE3
Concurrent Docetaxel Plus Cisplatin or Cisplatin Alone With IMRT in High Risk Nasopharyngeal Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Fludeoxyglucose F-18 PET/CT in Predicting Response to Chemotherapy in Patients With Stage IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery
- Status
- WITHDRAWN
- Phase
- PHASE2
Safety and Pharmacokinetics of Atezolizumab Combination Treatments in Participants With HER2-Positive and HER2-Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Alectinib Versus Pemetrexed or Docetaxel in Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) Participants Previously Treated With Platinum-Based Chemotherapy and Crizotinib
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate Ibrutinib Combination Therapy in Patients With Selected Gastrointestinal and Genitourinary Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Docetaxel and Carboplatin in Treating Patients With Metastatic, Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 Pathway
- Status
- COMPLETED
- Phase
- PHASE2